Application segmentation isolates the end‑use environments that drive demand for Medical Device Packaging Paper. The largest share, surgical instruments, accounts for roughly 35 % of total revenue because sterile, barrier‑grade paper is required for scalpel blades, forceps and reusable kits that undergo high‑temperature sterilization cycles. Diagnostic devices, representing about 25 % of the market, rely on lightweight, moisture‑resistant paper for test strips, biosensor cartridges and point‑of‑care kits where rapid unpackaging and low‑profile packaging are critical. Therapeutic devices contribute around 20 % and include paper wraps for infusion sets, wound‑care dressings and disposable respiratory components that demand controlled breathability and tear resistance. Implantable devices, at 15 %, use high‑purity, low‑particulate paper for sterile trays and packaging of pacemakers, stents and orthopedic implants, where particulate contamination directly impacts patient safety. The residual 5 % classified as “Other” captures niche applications such as veterinary devices and research‑grade instruments. These application segments collectively define the market’s size and growth trajectory.